Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon non-Hodgkin’s T-cell lymphoma [45,46], characterized by a monoclonal population of CD30+ large anaplastic cells, negative anaplastic lymphoma kinase and variable expression of lymphocyte T and EMA markers [28,47]. Here, ALK is linked to anaplastic large cell lymphoma.